首页|期刊导航|mLife|Cefdinir reprograms Gram-positive bacteria to synergize with lysozyme against superbugs

Cefdinir reprograms Gram-positive bacteria to synergize with lysozyme against superbugsOA

中文摘要

Multidrug-resistant(MDR)bacteria pose a critical global health threat,urgently requiring solutions.Cefdinir,the highest-selling third-generation cephalosporin but one now facing clinical obsolescence due to escalating resistance,is conventionally classified as a nascent cell wall synthesis inhibitor.This study challenges this understanding by demonstrating that cefdinir renders existing cell walls negatively charged,thereby synergizing with ubiquitous lysozyme and simultaneously restoring both agents'efficacy against a broad spectrum of MDR Gram-positive superbugs without driving resistance.Specifically,cefdinir is unexpectedly shown to post-transcriptionally increase the levels of clustered enzymes in lipoteichoic acid(LTA)and wall teichoic acid(WTA)synthesis pathways,including TarA,TarB,TarD,TarF,TarH,TarK,TarL,TarS,and FmtA,thereby enhancing cell wall electronegativity to remodel existing cell wall into a lysozyme-susceptible state,in which TarS is identified for the first time by mass spectrometry.The combination of cefdinir and lysozyme also significantly suppresses biofilm formation and minimizes de novo resistance mutations.Antibacterial efficacy of combination therapy is validated in both cell-based infection models and rat skin infection models,demonstrating strong translational potential.Given the established safety profiles of both agents,this sensitization strategy can be applied to human clinical research to combat MDR Gram-positive bacterial infections.

Qi Zhang;Yang Yang;Shuqi Li;Zhao Liu;Chun-Kit Lee;Chi-Bun Ko;Qian Zhao

State Key Laboratory of Chemical Biology and Drug Discovery,Department of Applied Biology and Chemical Technology,The Hong Kong Polytechnic University,Hong Kong,China Centre for Eye and Vision Research(CEVR),Hong Kong Science Park,Hong Kong,ChinaState Key Laboratory of Chemical Biology and Drug Discovery,Department of Applied Biology and Chemical Technology,The Hong Kong Polytechnic University,Hong Kong,China Centre for Eye and Vision Research(CEVR),Hong Kong Science Park,Hong Kong,ChinaState Key Laboratory of Chemical Biology and Drug Discovery,Department of Applied Biology and Chemical Technology,The Hong Kong Polytechnic University,Hong Kong,ChinaState Key Laboratory of Chemical Biology and Drug Discovery,Department of Applied Biology and Chemical Technology,The Hong Kong Polytechnic University,Hong Kong,China Centre for Eye and Vision Research(CEVR),Hong Kong Science Park,Hong Kong,ChinaState Key Laboratory of Chemical Biology and Drug Discovery,Department of Applied Biology and Chemical Technology,The Hong Kong Polytechnic University,Hong Kong,ChinaState Key Laboratory of Chemical Biology and Drug Discovery,Department of Applied Biology and Chemical Technology,The Hong Kong Polytechnic University,Hong Kong,ChinaState Key Laboratory of Chemical Biology and Drug Discovery,Department of Applied Biology and Chemical Technology,The Hong Kong Polytechnic University,Hong Kong,China Centre for Eye and Vision Research(CEVR),Hong Kong Science Park,Hong Kong,China

医药卫生

antimicrobial resistancecefdinirlipoteichoic acidlysozymewall teichoic acid

《mLife》 2026 (3)

P.355-368,14

supported by the annual budget of the Centre for Eye and Vision Research Limited(CEVR),InnoHK initiative,and the Hong Kong Special Administrative Region Governmentfunded by Shenzhen Research Institute Startup Funding(ZXLX20230728-00001)the Research Center for SHARP Vision(RSCV),The Hong Kong Polytechnic University(P0041210).

10.1002/mlf2.70080

评论